Pure Global AI
NCT06250231Not yet recruiting

Knowledge and Attitude Towards Fertility Among Emirati Infertile Patients

ART Fertility Clinics LLCClinicalTrials.govother
Verified
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
No intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
ART Fertility Clinics LLC
Location
Abu Dhabi,Al Ain, United Arab Emirates
Timeline & enrollment
Phase
N/A
Start date
Mar 31, 2024
End date
Apr 30, 2025
Enrollment
400 participants
Primary outcome

Understanding Knowledge and Attitudes of Emirati Infertility Patients Towards Fertility Issues

Summary

Infertility is on the rise worldwide due to multiple reasons. Proper and timely diagnosis
 makes the treatment easier and more acceptable by the couple. Lack of fertility knowledge
 however delays necessary investigations and sometimes reduces chances of success as a
 consequence of a delay in patients / couples approaching infertility clinics. Assessing the
 fertility knowledge of the Emirati infertility patients would help us to understand better
 the cultural aspects of fertility, the driving forces for having children and how much
 patients actually know about predisposing factors for infertility. This in turn would improve
 counseling and possible set knowledge campaigns to increase awareness.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06250231
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06250231 through Pure Global AI's free database. This phase not specified trial is sponsored by ART Fertility Clinics LLC and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.